Global and Regional Brain Monitoring

Brain Monitoring Comprehensive Study by Type (Computerized Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) Scanners, Positron Emission Tomography (PET) Scanners, Electroencephalograph (EEG) Devices, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices, Others (Sleep Monitoring Devices, Cerebral Oximeters and Others)), Application (Hospitals, Neurology Centers, Clinics & Ambulatory Surgical Centers, Diagnostic Centers, Others (Ambulances & Others)), Usability Type (Disposable, Reusable), Disease Type (Dementia, Epilepsy, Huntington's Disease, Parkinson’s Disease, Traumatic Brain Injury (TBI), Sleep Disorders, Other (Headache Disorders, Stroke and Others)), Procedure Type (Invasive Devices, Non-invasive Devices) Players and Region - Global Market Outlook to 2030

Brain Monitoring Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 20.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Brain Monitoring Market Scope
Brain monitoring is a procedure to monitor and diagnose abnormal activities by exploring the structure and functions of the brain. This procedure involves the use of various brain monitoring devices includes electroencephalography devices, intracranial pressure monitors, and magnetoencephalography to track brain functions and help to monitor neural and electrical activity in the brain. According to WHO, Epilepsy accounts for a significant proportion of the world’s disease burden, affecting more than 50 million people worldwide. The World Health Organization (WHO) has devised a Mental Health Action Plan 2013-2020 with certain objectives in order to provide comprehensive responsive mental health and social care services to the population. Neurological disease burden is seen higher in developing nations, which has resulted in renewed efforts by the Government and the Non-Government agencies to tackle these disease.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledAdvanced Brain Monitoring (United States), Nihon Kohden Corporation (Japan), Natus Medical, Inc. (United States), Philips Healthcare (Netherlands), GE Healthcare (United States), Siemens Healthineers (Germany), Compumedics, Ltd. (Australia), Medtronic (Ireland), CAS Medical Systems, Inc. (United States), Drägerwerk AG & Co. KGaA (Germany), Masimo Corporation (United States), Spiegelberg GmbH & Co. KG (Germany) and Cadwell Industries (United States)
CAGR20.3%


Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Brain Monitoring market throughout the predicted period.

Advanced Brain Monitoring (United States), Nihon Kohden Corporation (Japan), Natus Medical, Inc. (United States), Philips Healthcare (Netherlands), GE Healthcare (United States), Siemens Healthineers (Germany), Compumedics, Ltd. (Australia), Medtronic (Ireland), CAS Medical Systems, Inc. (United States), Drägerwerk AG & Co. KGaA (Germany), Masimo Corporation (United States), Spiegelberg GmbH & Co. KG (Germany) and Cadwell Industries (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are NeuroWave Systems, Inc. (United States), Nonin Medical, Inc. (United States), Integra LifeSciences Corporation (United States), Neurosoft (Russia) and Rimed (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Brain Monitoring market by Type , by Application (Hospitals, Neurology Centers, Clinics & Ambulatory Surgical Centers, Diagnostic Centers and Others (Ambulances & Others)) and Region with country level break-up.

On the basis of geography, the market of Brain Monitoring has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.




Influencing Trend:
Technological Advancements and Innovations in Products

Market Growth Drivers:
Rising Incidence and Prevalence of Neurological Disorders Globally, Increasing Awareness About Neurodegenerative Disorders Diseases, and The Growth in the Number of Traumatic Brain Injuries

Challenges:
The Cost Factor Associated with these Types of Equipment Used to Monitor Brain Activity

Restraints:
The Dearth of Skilled Professionals to Effectively Operate Brain Monitoring Devices in Developing Nations and Unfavourable Reimbursement Policies

Opportunities:
Increasing Applications of Brain Monitoring In Clinical Trials, Growing Demand for Invasive devices and Increasing Application in Clinical Trials and Expansion of Therapeutic Applications of Brain Monitoring Devices is Providing an Opportunity to the Market Players

Key Target Audience
Brain Monitoring Device and Equipment Manufacturers, Distributors/Traders/Wholesalers, Brain Monitoring Device Subcomponent Manufacturers, Industry Association, Diagnostic Centers, Neurological Centers, Health Centers/Clinics, End Users and Others

Report Objectives / Segmentation Covered

By Type
  • Computerized Tomography (CT) Scanners
  • Magnetic Resonance Imaging (MRI) Scanners
  • Positron Emission Tomography (PET) Scanners
  • Electroencephalograph (EEG) Devices
  • Magnetoencephalography (MEG) Devices
  • Transcranial Doppler (TCD) Devices
  • Others (Sleep Monitoring Devices, Cerebral Oximeters and Others)
By Application
  • Hospitals
  • Neurology Centers
  • Clinics & Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others (Ambulances & Others)
By Usability Type
  • Disposable
  • Reusable

By Disease Type
  • Dementia
  • Epilepsy
  • Huntington's Disease
  • Parkinson’s Disease
  • Traumatic Brain Injury (TBI)
  • Sleep Disorders
  • Other (Headache Disorders, Stroke and Others)

By Procedure Type
  • Invasive Devices
  • Non-invasive Devices

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Incidence and Prevalence of Neurological Disorders Globally
      • 3.2.2. Increasing Awareness About Neurodegenerative Disorders Diseases,
      • 3.2.3. The Growth in the Number of Traumatic Brain Injuries
    • 3.3. Market Challenges
      • 3.3.1. The Cost Factor Associated with these Types of Equipment Used to Monitor Brain Activity
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements and Innovations in Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Brain Monitoring, by Type, Application, Usability Type, Disease Type, Procedure Type and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Brain Monitoring (Value)
      • 5.2.1. Global Brain Monitoring by: Type (Value)
        • 5.2.1.1. Computerized Tomography (CT) Scanners
        • 5.2.1.2. Magnetic Resonance Imaging (MRI) Scanners
        • 5.2.1.3. Positron Emission Tomography (PET) Scanners
        • 5.2.1.4. Electroencephalograph (EEG) Devices
        • 5.2.1.5. Magnetoencephalography (MEG) Devices
        • 5.2.1.6. Transcranial Doppler (TCD) Devices
        • 5.2.1.7. Others (Sleep Monitoring Devices, Cerebral Oximeters and Others)
      • 5.2.2. Global Brain Monitoring by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Neurology Centers
        • 5.2.2.3. Clinics & Ambulatory Surgical Centers
        • 5.2.2.4. Diagnostic Centers
        • 5.2.2.5. Others (Ambulances & Others)
      • 5.2.3. Global Brain Monitoring by: Usability Type (Value)
        • 5.2.3.1. Disposable
        • 5.2.3.2. Reusable
      • 5.2.4. Global Brain Monitoring by: Disease Type (Value)
        • 5.2.4.1. Dementia
        • 5.2.4.2. Epilepsy
        • 5.2.4.3. Huntington's Disease
        • 5.2.4.4. Parkinson’s Disease
        • 5.2.4.5. Traumatic Brain Injury (TBI)
        • 5.2.4.6. Sleep Disorders
        • 5.2.4.7. Other (Headache Disorders, Stroke and Others)
      • 5.2.5. Global Brain Monitoring by: Procedure Type (Value)
        • 5.2.5.1. Invasive Devices
        • 5.2.5.2. Non-invasive Devices
      • 5.2.6. Global Brain Monitoring Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Brain Monitoring: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Advanced Brain Monitoring (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Nihon Kohden Corporation (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Natus Medical, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Philips Healthcare (Netherlands)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GE Healthcare (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Siemens Healthineers (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Compumedics, Ltd. (Australia)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Medtronic (Ireland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. CAS Medical Systems, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Drägerwerk AG & Co. KGaA (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Masimo Corporation (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Spiegelberg GmbH & Co. KG (Germany)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Cadwell Industries (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Brain Monitoring Sale, by Type, Application, Usability Type, Disease Type, Procedure Type and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Brain Monitoring (Value)
      • 7.2.1. Global Brain Monitoring by: Type (Value)
        • 7.2.1.1. Computerized Tomography (CT) Scanners
        • 7.2.1.2. Magnetic Resonance Imaging (MRI) Scanners
        • 7.2.1.3. Positron Emission Tomography (PET) Scanners
        • 7.2.1.4. Electroencephalograph (EEG) Devices
        • 7.2.1.5. Magnetoencephalography (MEG) Devices
        • 7.2.1.6. Transcranial Doppler (TCD) Devices
        • 7.2.1.7. Others (Sleep Monitoring Devices, Cerebral Oximeters and Others)
      • 7.2.2. Global Brain Monitoring by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Neurology Centers
        • 7.2.2.3. Clinics & Ambulatory Surgical Centers
        • 7.2.2.4. Diagnostic Centers
        • 7.2.2.5. Others (Ambulances & Others)
      • 7.2.3. Global Brain Monitoring by: Usability Type (Value)
        • 7.2.3.1. Disposable
        • 7.2.3.2. Reusable
      • 7.2.4. Global Brain Monitoring by: Disease Type (Value)
        • 7.2.4.1. Dementia
        • 7.2.4.2. Epilepsy
        • 7.2.4.3. Huntington's Disease
        • 7.2.4.4. Parkinson’s Disease
        • 7.2.4.5. Traumatic Brain Injury (TBI)
        • 7.2.4.6. Sleep Disorders
        • 7.2.4.7. Other (Headache Disorders, Stroke and Others)
      • 7.2.5. Global Brain Monitoring by: Procedure Type (Value)
        • 7.2.5.1. Invasive Devices
        • 7.2.5.2. Non-invasive Devices
      • 7.2.6. Global Brain Monitoring Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Brain Monitoring: by Type(USD Million)
  • Table 2. Brain Monitoring Computerized Tomography (CT) Scanners , by Region USD Million (2018-2023)
  • Table 3. Brain Monitoring Magnetic Resonance Imaging (MRI) Scanners , by Region USD Million (2018-2023)
  • Table 4. Brain Monitoring Positron Emission Tomography (PET) Scanners , by Region USD Million (2018-2023)
  • Table 5. Brain Monitoring Electroencephalograph (EEG) Devices , by Region USD Million (2018-2023)
  • Table 6. Brain Monitoring Magnetoencephalography (MEG) Devices , by Region USD Million (2018-2023)
  • Table 7. Brain Monitoring Transcranial Doppler (TCD) Devices , by Region USD Million (2018-2023)
  • Table 8. Brain Monitoring Others (Sleep Monitoring Devices, Cerebral Oximeters and Others) , by Region USD Million (2018-2023)
  • Table 9. Brain Monitoring: by Application(USD Million)
  • Table 10. Brain Monitoring Hospitals , by Region USD Million (2018-2023)
  • Table 11. Brain Monitoring Neurology Centers , by Region USD Million (2018-2023)
  • Table 12. Brain Monitoring Clinics & Ambulatory Surgical Centers , by Region USD Million (2018-2023)
  • Table 13. Brain Monitoring Diagnostic Centers , by Region USD Million (2018-2023)
  • Table 14. Brain Monitoring Others (Ambulances & Others) , by Region USD Million (2018-2023)
  • Table 15. Brain Monitoring: by Usability Type(USD Million)
  • Table 16. Brain Monitoring Disposable , by Region USD Million (2018-2023)
  • Table 17. Brain Monitoring Reusable , by Region USD Million (2018-2023)
  • Table 18. Brain Monitoring: by Disease Type(USD Million)
  • Table 19. Brain Monitoring Dementia , by Region USD Million (2018-2023)
  • Table 20. Brain Monitoring Epilepsy , by Region USD Million (2018-2023)
  • Table 21. Brain Monitoring Huntington's Disease , by Region USD Million (2018-2023)
  • Table 22. Brain Monitoring Parkinson’s Disease , by Region USD Million (2018-2023)
  • Table 23. Brain Monitoring Traumatic Brain Injury (TBI) , by Region USD Million (2018-2023)
  • Table 24. Brain Monitoring Sleep Disorders , by Region USD Million (2018-2023)
  • Table 25. Brain Monitoring Other (Headache Disorders, Stroke and Others) , by Region USD Million (2018-2023)
  • Table 26. Brain Monitoring: by Procedure Type(USD Million)
  • Table 27. Brain Monitoring Invasive Devices , by Region USD Million (2018-2023)
  • Table 28. Brain Monitoring Non-invasive Devices , by Region USD Million (2018-2023)
  • Table 29. South America Brain Monitoring, by Country USD Million (2018-2023)
  • Table 30. South America Brain Monitoring, by Type USD Million (2018-2023)
  • Table 31. South America Brain Monitoring, by Application USD Million (2018-2023)
  • Table 32. South America Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 33. South America Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 34. South America Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 35. Brazil Brain Monitoring, by Type USD Million (2018-2023)
  • Table 36. Brazil Brain Monitoring, by Application USD Million (2018-2023)
  • Table 37. Brazil Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 38. Brazil Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 39. Brazil Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 40. Argentina Brain Monitoring, by Type USD Million (2018-2023)
  • Table 41. Argentina Brain Monitoring, by Application USD Million (2018-2023)
  • Table 42. Argentina Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 43. Argentina Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 44. Argentina Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 45. Rest of South America Brain Monitoring, by Type USD Million (2018-2023)
  • Table 46. Rest of South America Brain Monitoring, by Application USD Million (2018-2023)
  • Table 47. Rest of South America Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 48. Rest of South America Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 49. Rest of South America Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 50. Asia Pacific Brain Monitoring, by Country USD Million (2018-2023)
  • Table 51. Asia Pacific Brain Monitoring, by Type USD Million (2018-2023)
  • Table 52. Asia Pacific Brain Monitoring, by Application USD Million (2018-2023)
  • Table 53. Asia Pacific Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 54. Asia Pacific Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 55. Asia Pacific Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 56. China Brain Monitoring, by Type USD Million (2018-2023)
  • Table 57. China Brain Monitoring, by Application USD Million (2018-2023)
  • Table 58. China Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 59. China Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 60. China Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 61. Japan Brain Monitoring, by Type USD Million (2018-2023)
  • Table 62. Japan Brain Monitoring, by Application USD Million (2018-2023)
  • Table 63. Japan Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 64. Japan Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 65. Japan Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 66. India Brain Monitoring, by Type USD Million (2018-2023)
  • Table 67. India Brain Monitoring, by Application USD Million (2018-2023)
  • Table 68. India Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 69. India Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 70. India Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 71. South Korea Brain Monitoring, by Type USD Million (2018-2023)
  • Table 72. South Korea Brain Monitoring, by Application USD Million (2018-2023)
  • Table 73. South Korea Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 74. South Korea Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 75. South Korea Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 76. Taiwan Brain Monitoring, by Type USD Million (2018-2023)
  • Table 77. Taiwan Brain Monitoring, by Application USD Million (2018-2023)
  • Table 78. Taiwan Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 79. Taiwan Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 80. Taiwan Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 81. Australia Brain Monitoring, by Type USD Million (2018-2023)
  • Table 82. Australia Brain Monitoring, by Application USD Million (2018-2023)
  • Table 83. Australia Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 84. Australia Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 85. Australia Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 86. Rest of Asia-Pacific Brain Monitoring, by Type USD Million (2018-2023)
  • Table 87. Rest of Asia-Pacific Brain Monitoring, by Application USD Million (2018-2023)
  • Table 88. Rest of Asia-Pacific Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 89. Rest of Asia-Pacific Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 90. Rest of Asia-Pacific Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 91. Europe Brain Monitoring, by Country USD Million (2018-2023)
  • Table 92. Europe Brain Monitoring, by Type USD Million (2018-2023)
  • Table 93. Europe Brain Monitoring, by Application USD Million (2018-2023)
  • Table 94. Europe Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 95. Europe Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 96. Europe Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 97. Germany Brain Monitoring, by Type USD Million (2018-2023)
  • Table 98. Germany Brain Monitoring, by Application USD Million (2018-2023)
  • Table 99. Germany Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 100. Germany Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 101. Germany Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 102. France Brain Monitoring, by Type USD Million (2018-2023)
  • Table 103. France Brain Monitoring, by Application USD Million (2018-2023)
  • Table 104. France Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 105. France Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 106. France Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 107. Italy Brain Monitoring, by Type USD Million (2018-2023)
  • Table 108. Italy Brain Monitoring, by Application USD Million (2018-2023)
  • Table 109. Italy Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 110. Italy Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 111. Italy Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 112. United Kingdom Brain Monitoring, by Type USD Million (2018-2023)
  • Table 113. United Kingdom Brain Monitoring, by Application USD Million (2018-2023)
  • Table 114. United Kingdom Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 115. United Kingdom Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 116. United Kingdom Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 117. Netherlands Brain Monitoring, by Type USD Million (2018-2023)
  • Table 118. Netherlands Brain Monitoring, by Application USD Million (2018-2023)
  • Table 119. Netherlands Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 120. Netherlands Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 121. Netherlands Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 122. Rest of Europe Brain Monitoring, by Type USD Million (2018-2023)
  • Table 123. Rest of Europe Brain Monitoring, by Application USD Million (2018-2023)
  • Table 124. Rest of Europe Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 125. Rest of Europe Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 126. Rest of Europe Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 127. MEA Brain Monitoring, by Country USD Million (2018-2023)
  • Table 128. MEA Brain Monitoring, by Type USD Million (2018-2023)
  • Table 129. MEA Brain Monitoring, by Application USD Million (2018-2023)
  • Table 130. MEA Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 131. MEA Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 132. MEA Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 133. Middle East Brain Monitoring, by Type USD Million (2018-2023)
  • Table 134. Middle East Brain Monitoring, by Application USD Million (2018-2023)
  • Table 135. Middle East Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 136. Middle East Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 137. Middle East Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 138. Africa Brain Monitoring, by Type USD Million (2018-2023)
  • Table 139. Africa Brain Monitoring, by Application USD Million (2018-2023)
  • Table 140. Africa Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 141. Africa Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 142. Africa Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 143. North America Brain Monitoring, by Country USD Million (2018-2023)
  • Table 144. North America Brain Monitoring, by Type USD Million (2018-2023)
  • Table 145. North America Brain Monitoring, by Application USD Million (2018-2023)
  • Table 146. North America Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 147. North America Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 148. North America Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 149. United States Brain Monitoring, by Type USD Million (2018-2023)
  • Table 150. United States Brain Monitoring, by Application USD Million (2018-2023)
  • Table 151. United States Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 152. United States Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 153. United States Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 154. Canada Brain Monitoring, by Type USD Million (2018-2023)
  • Table 155. Canada Brain Monitoring, by Application USD Million (2018-2023)
  • Table 156. Canada Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 157. Canada Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 158. Canada Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 159. Mexico Brain Monitoring, by Type USD Million (2018-2023)
  • Table 160. Mexico Brain Monitoring, by Application USD Million (2018-2023)
  • Table 161. Mexico Brain Monitoring, by Usability Type USD Million (2018-2023)
  • Table 162. Mexico Brain Monitoring, by Disease Type USD Million (2018-2023)
  • Table 163. Mexico Brain Monitoring, by Procedure Type USD Million (2018-2023)
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Company Basic Information, Sales Area and Its Competitors
  • Table 172. Company Basic Information, Sales Area and Its Competitors
  • Table 173. Company Basic Information, Sales Area and Its Competitors
  • Table 174. Company Basic Information, Sales Area and Its Competitors
  • Table 175. Company Basic Information, Sales Area and Its Competitors
  • Table 176. Company Basic Information, Sales Area and Its Competitors
  • Table 177. Brain Monitoring: by Type(USD Million)
  • Table 178. Brain Monitoring Computerized Tomography (CT) Scanners , by Region USD Million (2025-2030)
  • Table 179. Brain Monitoring Magnetic Resonance Imaging (MRI) Scanners , by Region USD Million (2025-2030)
  • Table 180. Brain Monitoring Positron Emission Tomography (PET) Scanners , by Region USD Million (2025-2030)
  • Table 181. Brain Monitoring Electroencephalograph (EEG) Devices , by Region USD Million (2025-2030)
  • Table 182. Brain Monitoring Magnetoencephalography (MEG) Devices , by Region USD Million (2025-2030)
  • Table 183. Brain Monitoring Transcranial Doppler (TCD) Devices , by Region USD Million (2025-2030)
  • Table 184. Brain Monitoring Others (Sleep Monitoring Devices, Cerebral Oximeters and Others) , by Region USD Million (2025-2030)
  • Table 185. Brain Monitoring: by Application(USD Million)
  • Table 186. Brain Monitoring Hospitals , by Region USD Million (2025-2030)
  • Table 187. Brain Monitoring Neurology Centers , by Region USD Million (2025-2030)
  • Table 188. Brain Monitoring Clinics & Ambulatory Surgical Centers , by Region USD Million (2025-2030)
  • Table 189. Brain Monitoring Diagnostic Centers , by Region USD Million (2025-2030)
  • Table 190. Brain Monitoring Others (Ambulances & Others) , by Region USD Million (2025-2030)
  • Table 191. Brain Monitoring: by Usability Type(USD Million)
  • Table 192. Brain Monitoring Disposable , by Region USD Million (2025-2030)
  • Table 193. Brain Monitoring Reusable , by Region USD Million (2025-2030)
  • Table 194. Brain Monitoring: by Disease Type(USD Million)
  • Table 195. Brain Monitoring Dementia , by Region USD Million (2025-2030)
  • Table 196. Brain Monitoring Epilepsy , by Region USD Million (2025-2030)
  • Table 197. Brain Monitoring Huntington's Disease , by Region USD Million (2025-2030)
  • Table 198. Brain Monitoring Parkinson’s Disease , by Region USD Million (2025-2030)
  • Table 199. Brain Monitoring Traumatic Brain Injury (TBI) , by Region USD Million (2025-2030)
  • Table 200. Brain Monitoring Sleep Disorders , by Region USD Million (2025-2030)
  • Table 201. Brain Monitoring Other (Headache Disorders, Stroke and Others) , by Region USD Million (2025-2030)
  • Table 202. Brain Monitoring: by Procedure Type(USD Million)
  • Table 203. Brain Monitoring Invasive Devices , by Region USD Million (2025-2030)
  • Table 204. Brain Monitoring Non-invasive Devices , by Region USD Million (2025-2030)
  • Table 205. South America Brain Monitoring, by Country USD Million (2025-2030)
  • Table 206. South America Brain Monitoring, by Type USD Million (2025-2030)
  • Table 207. South America Brain Monitoring, by Application USD Million (2025-2030)
  • Table 208. South America Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 209. South America Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 210. South America Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 211. Brazil Brain Monitoring, by Type USD Million (2025-2030)
  • Table 212. Brazil Brain Monitoring, by Application USD Million (2025-2030)
  • Table 213. Brazil Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 214. Brazil Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 215. Brazil Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 216. Argentina Brain Monitoring, by Type USD Million (2025-2030)
  • Table 217. Argentina Brain Monitoring, by Application USD Million (2025-2030)
  • Table 218. Argentina Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 219. Argentina Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 220. Argentina Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 221. Rest of South America Brain Monitoring, by Type USD Million (2025-2030)
  • Table 222. Rest of South America Brain Monitoring, by Application USD Million (2025-2030)
  • Table 223. Rest of South America Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 224. Rest of South America Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 225. Rest of South America Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 226. Asia Pacific Brain Monitoring, by Country USD Million (2025-2030)
  • Table 227. Asia Pacific Brain Monitoring, by Type USD Million (2025-2030)
  • Table 228. Asia Pacific Brain Monitoring, by Application USD Million (2025-2030)
  • Table 229. Asia Pacific Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 230. Asia Pacific Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 231. Asia Pacific Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 232. China Brain Monitoring, by Type USD Million (2025-2030)
  • Table 233. China Brain Monitoring, by Application USD Million (2025-2030)
  • Table 234. China Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 235. China Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 236. China Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 237. Japan Brain Monitoring, by Type USD Million (2025-2030)
  • Table 238. Japan Brain Monitoring, by Application USD Million (2025-2030)
  • Table 239. Japan Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 240. Japan Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 241. Japan Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 242. India Brain Monitoring, by Type USD Million (2025-2030)
  • Table 243. India Brain Monitoring, by Application USD Million (2025-2030)
  • Table 244. India Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 245. India Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 246. India Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 247. South Korea Brain Monitoring, by Type USD Million (2025-2030)
  • Table 248. South Korea Brain Monitoring, by Application USD Million (2025-2030)
  • Table 249. South Korea Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 250. South Korea Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 251. South Korea Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 252. Taiwan Brain Monitoring, by Type USD Million (2025-2030)
  • Table 253. Taiwan Brain Monitoring, by Application USD Million (2025-2030)
  • Table 254. Taiwan Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 255. Taiwan Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 256. Taiwan Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 257. Australia Brain Monitoring, by Type USD Million (2025-2030)
  • Table 258. Australia Brain Monitoring, by Application USD Million (2025-2030)
  • Table 259. Australia Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 260. Australia Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 261. Australia Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 262. Rest of Asia-Pacific Brain Monitoring, by Type USD Million (2025-2030)
  • Table 263. Rest of Asia-Pacific Brain Monitoring, by Application USD Million (2025-2030)
  • Table 264. Rest of Asia-Pacific Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 265. Rest of Asia-Pacific Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 266. Rest of Asia-Pacific Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 267. Europe Brain Monitoring, by Country USD Million (2025-2030)
  • Table 268. Europe Brain Monitoring, by Type USD Million (2025-2030)
  • Table 269. Europe Brain Monitoring, by Application USD Million (2025-2030)
  • Table 270. Europe Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 271. Europe Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 272. Europe Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 273. Germany Brain Monitoring, by Type USD Million (2025-2030)
  • Table 274. Germany Brain Monitoring, by Application USD Million (2025-2030)
  • Table 275. Germany Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 276. Germany Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 277. Germany Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 278. France Brain Monitoring, by Type USD Million (2025-2030)
  • Table 279. France Brain Monitoring, by Application USD Million (2025-2030)
  • Table 280. France Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 281. France Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 282. France Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 283. Italy Brain Monitoring, by Type USD Million (2025-2030)
  • Table 284. Italy Brain Monitoring, by Application USD Million (2025-2030)
  • Table 285. Italy Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 286. Italy Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 287. Italy Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 288. United Kingdom Brain Monitoring, by Type USD Million (2025-2030)
  • Table 289. United Kingdom Brain Monitoring, by Application USD Million (2025-2030)
  • Table 290. United Kingdom Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 291. United Kingdom Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 292. United Kingdom Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 293. Netherlands Brain Monitoring, by Type USD Million (2025-2030)
  • Table 294. Netherlands Brain Monitoring, by Application USD Million (2025-2030)
  • Table 295. Netherlands Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 296. Netherlands Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 297. Netherlands Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 298. Rest of Europe Brain Monitoring, by Type USD Million (2025-2030)
  • Table 299. Rest of Europe Brain Monitoring, by Application USD Million (2025-2030)
  • Table 300. Rest of Europe Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 301. Rest of Europe Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 302. Rest of Europe Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 303. MEA Brain Monitoring, by Country USD Million (2025-2030)
  • Table 304. MEA Brain Monitoring, by Type USD Million (2025-2030)
  • Table 305. MEA Brain Monitoring, by Application USD Million (2025-2030)
  • Table 306. MEA Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 307. MEA Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 308. MEA Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 309. Middle East Brain Monitoring, by Type USD Million (2025-2030)
  • Table 310. Middle East Brain Monitoring, by Application USD Million (2025-2030)
  • Table 311. Middle East Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 312. Middle East Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 313. Middle East Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 314. Africa Brain Monitoring, by Type USD Million (2025-2030)
  • Table 315. Africa Brain Monitoring, by Application USD Million (2025-2030)
  • Table 316. Africa Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 317. Africa Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 318. Africa Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 319. North America Brain Monitoring, by Country USD Million (2025-2030)
  • Table 320. North America Brain Monitoring, by Type USD Million (2025-2030)
  • Table 321. North America Brain Monitoring, by Application USD Million (2025-2030)
  • Table 322. North America Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 323. North America Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 324. North America Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 325. United States Brain Monitoring, by Type USD Million (2025-2030)
  • Table 326. United States Brain Monitoring, by Application USD Million (2025-2030)
  • Table 327. United States Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 328. United States Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 329. United States Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 330. Canada Brain Monitoring, by Type USD Million (2025-2030)
  • Table 331. Canada Brain Monitoring, by Application USD Million (2025-2030)
  • Table 332. Canada Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 333. Canada Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 334. Canada Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 335. Mexico Brain Monitoring, by Type USD Million (2025-2030)
  • Table 336. Mexico Brain Monitoring, by Application USD Million (2025-2030)
  • Table 337. Mexico Brain Monitoring, by Usability Type USD Million (2025-2030)
  • Table 338. Mexico Brain Monitoring, by Disease Type USD Million (2025-2030)
  • Table 339. Mexico Brain Monitoring, by Procedure Type USD Million (2025-2030)
  • Table 340. Research Programs/Design for This Report
  • Table 341. Key Data Information from Secondary Sources
  • Table 342. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Brain Monitoring: by Type USD Million (2018-2023)
  • Figure 5. Global Brain Monitoring: by Application USD Million (2018-2023)
  • Figure 6. Global Brain Monitoring: by Usability Type USD Million (2018-2023)
  • Figure 7. Global Brain Monitoring: by Disease Type USD Million (2018-2023)
  • Figure 8. Global Brain Monitoring: by Procedure Type USD Million (2018-2023)
  • Figure 9. South America Brain Monitoring Share (%), by Country
  • Figure 10. Asia Pacific Brain Monitoring Share (%), by Country
  • Figure 11. Europe Brain Monitoring Share (%), by Country
  • Figure 12. MEA Brain Monitoring Share (%), by Country
  • Figure 13. North America Brain Monitoring Share (%), by Country
  • Figure 14. Global Brain Monitoring share by Players 2023 (%)
  • Figure 15. Global Brain Monitoring share by Players (Top 3) 2023(%)
  • Figure 16. Global Brain Monitoring share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Advanced Brain Monitoring (United States) Revenue, Net Income and Gross profit
  • Figure 19. Advanced Brain Monitoring (United States) Revenue: by Geography 2023
  • Figure 20. Nihon Kohden Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 21. Nihon Kohden Corporation (Japan) Revenue: by Geography 2023
  • Figure 22. Natus Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Natus Medical, Inc. (United States) Revenue: by Geography 2023
  • Figure 24. Philips Healthcare (Netherlands) Revenue, Net Income and Gross profit
  • Figure 25. Philips Healthcare (Netherlands) Revenue: by Geography 2023
  • Figure 26. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 27. GE Healthcare (United States) Revenue: by Geography 2023
  • Figure 28. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Siemens Healthineers (Germany) Revenue: by Geography 2023
  • Figure 30. Compumedics, Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 31. Compumedics, Ltd. (Australia) Revenue: by Geography 2023
  • Figure 32. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 33. Medtronic (Ireland) Revenue: by Geography 2023
  • Figure 34. CAS Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. CAS Medical Systems, Inc. (United States) Revenue: by Geography 2023
  • Figure 36. Drägerwerk AG & Co. KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 37. Drägerwerk AG & Co. KGaA (Germany) Revenue: by Geography 2023
  • Figure 38. Masimo Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 39. Masimo Corporation (United States) Revenue: by Geography 2023
  • Figure 40. Spiegelberg GmbH & Co. KG (Germany) Revenue, Net Income and Gross profit
  • Figure 41. Spiegelberg GmbH & Co. KG (Germany) Revenue: by Geography 2023
  • Figure 42. Cadwell Industries (United States) Revenue, Net Income and Gross profit
  • Figure 43. Cadwell Industries (United States) Revenue: by Geography 2023
  • Figure 44. Global Brain Monitoring: by Type USD Million (2025-2030)
  • Figure 45. Global Brain Monitoring: by Application USD Million (2025-2030)
  • Figure 46. Global Brain Monitoring: by Usability Type USD Million (2025-2030)
  • Figure 47. Global Brain Monitoring: by Disease Type USD Million (2025-2030)
  • Figure 48. Global Brain Monitoring: by Procedure Type USD Million (2025-2030)
  • Figure 49. South America Brain Monitoring Share (%), by Country
  • Figure 50. Asia Pacific Brain Monitoring Share (%), by Country
  • Figure 51. Europe Brain Monitoring Share (%), by Country
  • Figure 52. MEA Brain Monitoring Share (%), by Country
  • Figure 53. North America Brain Monitoring Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Advanced Brain Monitoring (United States)
  • Nihon Kohden Corporation (Japan)
  • Natus Medical, Inc. (United States)
  • Philips Healthcare (Netherlands)
  • GE Healthcare (United States)
  • Siemens Healthineers (Germany)
  • Compumedics, Ltd. (Australia)
  • Medtronic (Ireland)
  • CAS Medical Systems, Inc. (United States)
  • Drägerwerk AG & Co. KGaA (Germany)
  • Masimo Corporation (United States)
  • Spiegelberg GmbH & Co. KG (Germany)
  • Cadwell Industries (United States)
Additional players considered in the study are as follows:
NeuroWave Systems, Inc. (United States) , Nonin Medical, Inc. (United States) , Integra LifeSciences Corporation (United States) , Neurosoft (Russia) , Rimed (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 240 Pages 64 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global and Regional Brain Monitoring Quantitative research analysis
Global and Regional Brain Monitoring Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Brain Monitoring Market are by type [Computerized Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) Scanners, Positron Emission Tomography (PET) Scanners, Electroencephalograph (EEG) Devices, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices and Others (Sleep Monitoring Devices, Cerebral Oximeters and Others)], by end use application [Hospitals, Neurology Centers, Clinics & Ambulatory Surgical Centers, Diagnostic Centers and Others (Ambulances & Others)].
The Brain Monitoring Market is gaining popularity and expected to see strong valuation by 2030.
  • Rising Incidence and Prevalence of Neurological Disorders Globally
  • Increasing Awareness About Neurodegenerative Disorders Diseases,
  • The Growth in the Number of Traumatic Brain Injuries

Know More About Global and Regional Brain Monitoring Report?

Have a Query? Click Here

Other Related Reports

Intrauterine Devices Comprehensive Study by Type (Hormonal Intrauterine Devices, Non-Hormonal Intrauterine Devices), Application (Hospitals, Community Health Centres, Gynecological Clinics, Others), ...
$ 3450
Intra-Oral Flat Panel Sensor Comprehensive Study by Type (CCD, CMOS), Application (Diagnostic Medical Imaging System, Veterinary System), Sales Channel (Direct, Indirect) Players and Region - Global ...
$ 3500
Insulin Pump Comprehensive Study by Type (Smart Pumps, Disposable Pumps, Traditional Pumps, Tethered Pumps, Untethered Pumps, Implantable Pumps), Application (Hospital, Clinics, Health Care market), ...
$ 3750
Blood Collection System Comprehensive Study by Type (Serum Separating Tubes, EDTA Tubes, Plasma Separation Tube, Others), Application (Venous Blood Collection, Capillary Blood Collection), Method (Au...
$ 3650
Interventional Cardiology Devices Comprehensive Study by Type (Catheters, Coronary Stents, Percutaneous Transluminal Coronary Angioplasty Balloons(PTCA), Percutaneous Transluminal Coronary Angioplast...
$ 3650
Medical Devices Comprehensive Study by Type (Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging, IVD, MIS, Wound Management, Diabetes Care Devices, Ophthalmic Devices, Dental Devices, Nep...
$ 3750